These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 26194272

  • 1. Improvement of β-cell function ameliorated glycemic variability in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion or in combination with sitagliptin treatment: a randomized control trial.
    Yuan G, Hu H, Wang S, Yang Q, Yu S, Sun W, Qian W, Mao C, Zhou L, Chen D, Wang Z, Gong Q, Wang D.
    Endocr J; 2015; 62(9):817-34. PubMed ID: 26194272
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.
    Yuan G, Jia J, Zhang C, Yu S, Dong S, Ye J, Zhu T, Tang B, Qian W, Wang D, Yang L, Zhou L, Mao C.
    Endocr J; 2014; 61(5):513-21. PubMed ID: 24621778
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the Effects of Continuous Subcutaneous Insulin Infusion and Add-On Therapy with Sitagliptin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus.
    Wan H, Zhao D, Shen J, Lu L, Zhang T, Chen Z.
    J Diabetes Res; 2016; 2016():9849328. PubMed ID: 26798658
    [Abstract] [Full Text] [Related]

  • 4. Effects of Liraglutide Combined with Short-Term Continuous Subcutaneous Insulin Infusion on Glycemic Control and Beta Cell Function in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Pilot Study.
    Ke W, Liu L, Liu J, Chen A, Deng W, Zhang P, Cao X, Liao Z, Xiao H, Liu J, Li Y.
    J Diabetes Res; 2016; 2016():6839735. PubMed ID: 26640805
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Continuous subcutaneous insulin infusion combined with liraglutide reduced glycemic variability and oxidative stress in type 2 diabetes mellitus: a study based on the flash glucose monitoring system.
    Li LQ, Yao MY, Ma JX, Xue P, Li YK.
    Endocr J; 2019 Oct 28; 66(10):871-880. PubMed ID: 31243192
    [Abstract] [Full Text] [Related]

  • 7. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP, Mo H, Liu BL, Tang WL, Deng XG, Su X, Yao L, Lin J, Feng Q, Peng J, Zhou ZG, Li YJ.
    Zhonghua Nei Ke Za Zhi; 2010 May 28; 49(5):405-9. PubMed ID: 20646415
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metformin add-on continuous subcutaneous insulin infusion on precise insulin doses in patients with type 2 diabetes.
    Li FF, Liu BL, Yin GP, Yan RN, Zhang DF, Wu JD, Ye L, Su XF, Ma JH.
    Sci Rep; 2018 Jun 26; 8(1):9713. PubMed ID: 29946148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Noninferiority effects on glycemic control and β-cell function improvement in newly diagnosed type 2 diabetes patients: basal insulin monotherapy versus continuous subcutaneous insulin infusion treatment.
    Zeng L, Lu H, Deng H, Mu P, Li X, Wang M.
    Diabetes Technol Ther; 2012 Jan 26; 14(1):35-42. PubMed ID: 21877913
    [Abstract] [Full Text] [Related]

  • 15. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
    Liu L, Ke W, Wan X, Zhang P, Cao X, Deng W, Li Y.
    Diabetes Res Clin Pract; 2015 May 26; 108(2):250-7. PubMed ID: 25765670
    [Abstract] [Full Text] [Related]

  • 16. Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
    Alba M, Ahrén B, Inzucchi SE, Guan Y, Mallick M, Xu L, O'Neill EA, Williams-Herman DE, Kaufman KD, Goldstein BJ.
    Diabetes Obes Metab; 2013 Dec 26; 15(12):1101-10. PubMed ID: 23782502
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.